Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Computational design of PD-L1 small molecule inhibitors for cancer therapy
Jaikanth Chandrasekaran, Senthilkumar Elumalai, Vidya Murugesan, et al.
Molecular Diversity (2022) Vol. 27, Iss. 4, pp. 1633-1644
Closed Access | Times Cited: 17

Showing 17 citing articles:

Inside PD-1/PD-L1,2 with their inhibitors
Nicolas Boisgerault, Philìppe Bertrand
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115465-115465
Open Access | Times Cited: 14
Progress in small-molecule inhibitors targeting PD-L1
J. Xu, Yuanfang Kong, Pengbo Zhu, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 4, pp. 1161-1175
Closed Access | Times Cited: 4
Development of small molecule drugs targeting immune checkpoints
Luoyi Chen, Xinchen Zhao, Xiaowei Liu, et al.
Cancer Biology and Medicine (2024), pp. 1-18
Open Access | Times Cited: 4
Characterizing tertiary lymphoid structures associated single-cell atlas in breast cancer patients
Xiaokai Fan, Daqin Feng, Dongmei Wei, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Computational Approaches Drive Developments in Immune-Oncology Therapies for PD-1/PD-L1 Immune Checkpoint Inhibitors
Patrícia Sobral, Vanessa C. C. Luz, João M. G. C. F. Almeida, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5908-5908
Open Access | Times Cited: 10
Advancements in drug discovery: integrating CADD tools and drug repurposing for PD-1/PD-L1 axis inhibition
Patrícia Sobral, T. Carvalho, Shiva Izadi, et al.
RSC Advances (2025) Vol. 15, Iss. 4, pp. 2298-2316
Open Access
A Comparative Molecular Dynamics Study of Food-Derived Compounds as PD-L1 Inhibitors: Insights Across Six Flavonoid Subgroups
Dejun Jiang, Hyuk-Ku Kwon, Oh Wook Kwon, et al.
Molecules (2025) Vol. 30, Iss. 4, pp. 907-907
Open Access
Immunomodulatory properties of HDAC6 inhibitors in cancer diseases: New chances for sophisticated drug design and treatment optimization
Bernhard Biersack, Bianca Nitzsche, Michael Höpfner
Seminars in Cell and Developmental Biology (2022) Vol. 154, pp. 286-294
Closed Access | Times Cited: 16
Engineering PD-L1 targeted liposomal canagliflozin achieves multimodal synergistic cancer therapy
Simeng Wang, Mengjun Sui, Quan Chen, et al.
Chemical Engineering Journal (2024) Vol. 498, pp. 155074-155074
Open Access | Times Cited: 2
Novel PD-L1-Targeted Phenyl-Pyrazolone Derivatives with Antioxidant Properties
Romain Regnault, Frédérique Klupsch, Hassiba El-Bouazzati, et al.
Molecules (2023) Vol. 28, Iss. 8, pp. 3491-3491
Open Access | Times Cited: 3
Screening of Phytochemicals Against Snake Venom Metalloproteinase: Molecular Docking and Simulation Based Computational Approaches
Ahmad Mohajja Alshammari
Archives of Pharmacy Practice (2022) Vol. 13, Iss. 3, pp. 76-84
Closed Access | Times Cited: 4
Structure-Based Screening Reveals a Ligand That Stabilizes the [2Fe-2S] Clusters of Human mitoNEET and Reduces Ovarian Cancer Cell Proliferation
Henri‐Baptiste Marjault, Yang‐Sung Sohn, Ke Zuo, et al.
The Journal of Physical Chemistry B (2022) Vol. 126, Iss. 46, pp. 9559-9565
Closed Access | Times Cited: 3
Folate receptor-targeted Camptothecin-loaded PLGA-Glutenin nanoparticles for effective breast cancer treatment
Raja Rajeswari Rajeshkumar, Theivendren Panneerselvam, Parasuraman Pavadai, et al.
Research Square (Research Square) (2024)
Open Access
Discovery of Daclatasvir as a potential PD-L1 inhibitor from drug repurposing
Mengmeng Sun, Shixuan Lv, Yanyan Pan, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107874-107874
Closed Access
In silico evaluation of some commercially available terpenoids as spike glycoprotein of SARS-CoV-2 – inhibitors using molecular dynamic approach
Arumugam Madeswaran, Brahmasundari Shanmugavel, Mohan Sellppan, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 2, pp. 1072-1078
Closed Access | Times Cited: 1
Folate Receptor-Targeted Camptothecin-Loaded PLGA-Glutenin Nanoparticles for Effective Breast cancer Treatment
Raja Rajeswari Rajeshkumar, Theivendren Panneerselvam, Parasuraman Pavadai, et al.
Journal of Polymers and the Environment (2024)
Closed Access
Interaction of telmisartan and related sartans with the programmed cell death-ligand 1 (PD-L1) protein dimer: a molecular docking analysis
Gérard Vergoten, Christian Bailly
Future Journal of Pharmaceutical Sciences (2023) Vol. 9, Iss. 1
Open Access
Page 1

Scroll to top